BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jaishankar D, Buhrman JS, Valyi-Nagy T, Gemeinhart RA, Shukla D. Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection. Invest Ophthalmol Vis Sci 2016;57:169-80. [PMID: 26780322 DOI: 10.1167/iovs.15-18365] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Lin KK, Chen YW, Yeh CT, Li PR, Lee JS, Hou CH, Hsiao CH, See LC. Comparing the natural progression and clinical features of keratoconus between pediatric and adult patients. Sci Rep 2022;12:8278. [PMID: 35585098 DOI: 10.1038/s41598-022-12070-2] [Reference Citation Analysis]
2 Pereira-da-mota AF, Phan C, Concheiro A, Jones L, Alvarez-lorenzo C. Testing drug release from medicated contact lenses: The missing link to predict in vivo performance. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Rykowska I, Nowak I, Nowak R. Soft Contact Lenses as Drug Delivery Systems: A Review. Molecules 2021;26:5577. [PMID: 34577045 DOI: 10.3390/molecules26185577] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
4 Kinaneh S, Khamaysi I, Karram T, Hamoud S. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy. Biosci Rep 2021;41:BSR20210290. [PMID: 34132790 DOI: 10.1042/BSR20210290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Suryawanshi RK, Patil CD, Koganti R, Singh SK, Ames JM, Shukla D. Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry. Pathogens 2021;10:803. [PMID: 34202835 DOI: 10.3390/pathogens10070803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Jones L, Hui A, Phan CM, Read ML, Azar D, Buch J, Ciolino JB, Naroo SA, Pall B, Romond K, Sankaridurg P, Schnider CM, Terry L, Willcox M. CLEAR - Contact lens technologies of the future. Cont Lens Anterior Eye 2021;44:398-430. [PMID: 33775384 DOI: 10.1016/j.clae.2021.02.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
7 Koganti R, Yadavalli T, Naqvi RA, Shukla D, Naqvi AR. Pathobiology and treatment of viral keratitis. Exp Eye Res 2021;205:108483. [PMID: 33556334 DOI: 10.1016/j.exer.2021.108483] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
8 Madavaraju K, Koganti R, Volety I, Yadavalli T, Shukla D. Herpes Simplex Virus Cell Entry Mechanisms: An Update. Front Cell Infect Microbiol 2020;10:617578. [PMID: 33537244 DOI: 10.3389/fcimb.2020.617578] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
9 Toffoletto N, Saramago B, Serro AP. Therapeutic Ophthalmic Lenses: A Review. Pharmaceutics 2020;13:36. [PMID: 33379411 DOI: 10.3390/pharmaceutics13010036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
10 Pandey M, Choudhury H, Abdul-Aziz A, Bhattamisra SK, Gorain B, Su JST, Tan CL, Chin WY, Yip KY. Advancement on Sustained Antiviral Ocular Drug Delivery for Herpes Simplex Virus Keratitis: Recent Update on Potential Investigation. Pharmaceutics 2020;13:E1. [PMID: 33374925 DOI: 10.3390/pharmaceutics13010001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
11 Sawant OB, Singh S, Wright RE 3rd, Jones KM, Titus MS, Dennis E, Hicks E, Majmudar PA, Kumar A, Mian SI. Prevalence of SARS-CoV-2 in human post-mortem ocular tissues. Ocul Surf 2021;19:322-9. [PMID: 33176215 DOI: 10.1016/j.jtos.2020.11.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 20.0] [Reference Citation Analysis]
12 Fan X, Torres-Luna C, Azadi M, Domszy R, Hu N, Yang A, David AE. Evaluation of commercial soft contact lenses for ocular drug delivery: A review. Acta Biomater 2020;115:60-74. [PMID: 32853799 DOI: 10.1016/j.actbio.2020.08.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
13 Wu D, Koganti R, Lambe UP, Yadavalli T, Nandi SS, Shukla D. Vaccines and Therapies in Development for SARS-CoV-2 Infections. J Clin Med 2020;9:E1885. [PMID: 32560227 DOI: 10.3390/jcm9061885] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
14 Agelidis A, Shukla D. Heparanase, Heparan Sulfate and Viral Infection. Adv Exp Med Biol 2020;1221:759-70. [PMID: 32274736 DOI: 10.1007/978-3-030-34521-1_32] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
15 Yadavalli T, Suryawanshi R, Ali M, Iqbal A, Koganti R, Ames J, Aakalu VK, Shukla D. Prior inhibition of AKT phosphorylation by BX795 can define a safer strategy to prevent herpes simplex virus-1 infection of the eye. Ocul Surf 2020;18:221-30. [PMID: 31770600 DOI: 10.1016/j.jtos.2019.11.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
16 Koganti R, Yadavalli T, Shukla D. Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections. Microorganisms 2019;7:E429. [PMID: 31658632 DOI: 10.3390/microorganisms7100429] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
17 Jaishankar D, Yakoub AM, Yadavalli T, Agelidis A, Thakkar N, Hadigal S, Ames J, Shukla D. An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye. Sci Transl Med 2018;10:eaan5861. [PMID: 29444978 DOI: 10.1126/scitranslmed.aan5861] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 11.5] [Reference Citation Analysis]
18 Yadavalli T, Ames J, Agelidis A, Suryawanshi R, Jaishankar D, Hopkins J, Thakkar N, Koujah L, Shukla D. Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery. Sci Adv 2019;5:eaax0780. [PMID: 31453334 DOI: 10.1126/sciadv.aax0780] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
19 Zaynutdinova GC. Мodern Approaches to the Treatment and Prevention of Recurrent of Ophthalmic Herpes. Review. Oftalʹmologiâ 2019;16:12-20. [DOI: 10.18008/1816-5095-2019-1s-12-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Royer DJ, Hendrix JF, Larabee CM, Reagan AM, Sjoelund VH, Robertson DM, Carr DJJ. Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection. Mucosal Immunol 2019;12:827-39. [PMID: 30670763 DOI: 10.1038/s41385-019-0131-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
21 Alvarez-Lorenzo C, Anguiano-Igea S, Varela-García A, Vivero-Lopez M, Concheiro A. Bioinspired hydrogels for drug-eluting contact lenses. Acta Biomater 2019;84:49-62. [PMID: 30448434 DOI: 10.1016/j.actbio.2018.11.020] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 14.0] [Reference Citation Analysis]
22 Kaltenbach DD, Jaishankar D, Hao M, Beer JC, Volin MV, Desai UR, Tiwari V. Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development. Front Pharmacol 2018;9:1315. [PMID: 30555321 DOI: 10.3389/fphar.2018.01315] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
23 Koujah L, Suryawanshi RK, Shukla D. Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea. Cell Mol Life Sci 2019;76:405-19. [PMID: 30327839 DOI: 10.1007/s00018-018-2938-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 12.0] [Reference Citation Analysis]
24 Lobo AM, Agelidis AM, Shukla D. Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation. Ocul Surf 2019;17:40-9. [PMID: 30317007 DOI: 10.1016/j.jtos.2018.10.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 14.4] [Reference Citation Analysis]
25 Hui A. Contact lenses for ophthalmic drug delivery. Clin Exp Optom 2017;100:494-512. [PMID: 28940532 DOI: 10.1111/cxo.12592] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
26 Yadavalli T, Agelidis A, Jaishankar D, Mangano K, Thakkar N, Penmetcha K, Shukla D. Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection. Mol Ther Nucleic Acids 2017;9:365-78. [PMID: 29246315 DOI: 10.1016/j.omtn.2017.10.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
27 Ţălu Ş, Bramowicz M, Kulesza S, Fiorillo I, Giovanzana S. Fractal Features and Surface Micromorphology of Unworn Surfaces of Rigid Gas Permeable Contact Lenses. Curr Eye Res 2017;42:1118-23. [PMID: 28443694 DOI: 10.1080/02713683.2017.1293115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Duggal N, Jaishankar D, Yadavalli T, Hadigal S, Mishra YK, Adelung R, Shukla D. Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas. Mol Vis 2017;23:26-38. [PMID: 28275313] [Reference Citation Analysis]
29 Qin G, Zhu Z, Li S, McDermott AM, Cai C. Development of ciprofloxacin-loaded contact lenses using fluorous chemistry. Biomaterials 2017;124:55-64. [PMID: 28188995 DOI: 10.1016/j.biomaterials.2017.01.046] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]